CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $29.14M, above the global median of $16.24M
- FinancialsAltman Z-Score 5.45: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
5.68%Above 5Y avg (4.84%)
Annual Rate
TWD 4.50Paid annual
Payout Ratio
64.7%Moderate
Payback Period
17.4 yr
Last Ex-Dividend
Mar 26, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
19.69BTWD618.01M · vs all stocks (USD)
Trailing P/E
11.35xRevenue (TTM)
6.65BTWD208.82M · vs all stocks (USD)
Profit Margin
26.04%Beta
0.1130xvs all stocks
52-Week Change
3.95%vs all stocks
Market Capitalization
19.69BTWD618.01M · vs all stocks (USD)
Enterprise Value
19.16BTWD601.25M · vs all stocks (USD)
Trailing P/E
11.35xForward P/E
13.06xPrice to Sales (TTM)
2.95xPrice to Book (MRQ)
2.83xEnterprise to Revenue
2.88xEnterprise to EBITDA
9.30xGross Margin
59.99%Profit Margin
26.04%Operating Margin
29.49%Return on Assets (TTM)
10.35%Return on Equity (TTM)
25.11%Revenue (TTM)
6.65BTWD208.82M · vs all stocks (USD)
Revenue per Share (TTM)
26.76TWDUpdated Aug 20, 2026Quarterly Revenue Growth
9.20%Gross Profit (TTM)
3.83BTWD120.21M · vs all stocks (USD)
EBITDA (TTM)
2.13BTWD66.91M · vs all stocks (USD)
Net Income (TTM)
1.73BTWD54.38M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
42.80%Operating Cash Flow (TTM)
1.96BTWD61.66M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
928.63MTWD29.14M · vs all stocks (USD)
Trailing Annual Dividend Rate
4.50TWDUpdated Aug 20, 2026Trailing Annual Dividend Yield
5.68%vs all stocks
5-Year Average Dividend Yield
4.84%vs all stocks
Payout Ratio
64.66%Minority Interest (Equity)
812.93MTWDFY2025 · Dec 31, 2025Revenue
6.45BTWDFY2025 · Dec 31, 2025Cost of Goods Sold
2.73BTWDFY2025 · Dec 31, 2025Gross Profit
3.72BTWDFY2025 · Dec 31, 2025Operating Income
1.70BTWD53.50M · vs all stocks (USD)
Pre-tax Income
2.13BTWDFY2025 · Dec 31, 2025Income Tax Expense
470.47MTWDFY2025 · Dec 31, 2025Net Income
1.65BTWDFY2025 · Dec 31, 2025EBIT
2.16BTWDFY2025 · Dec 31, 2025EBITDA (Income Statement)
2.35BTWDFY2025 · Dec 31, 2025Research & Development
194.35MTWDFY2025 · Dec 31, 2025Selling, General & Administrative
1.82BTWDFY2025 · Dec 31, 2025Non-operating Interest Income
75.08MTWDFY2025 · Dec 31, 2025Non-operating Interest Expense
38.66MTWDFY2025 · Dec 31, 2025EPS (Basic)
6.27TWDFY2025 · Dec 31, 2025EPS (Diluted)
6.26TWDFY2025 · Dec 31, 2025Basic Shares Outstanding
248.66MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
248.66MSharesFY2025 · Dec 31, 2025Minority Interests (P&L)
-95.58MTWDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00TWDFY2025 · Dec 31, 2025Operating Cash Flow
1.79BTWDFY2025 · Dec 31, 2025Free Cash Flow
1.70BTWDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.52BTWDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
2.13BTWDFY2025 · Dec 31, 2025Other Non-cash Items
-24.40MTWDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-176.94MTWDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-134.59MTWDFY2025 · Dec 31, 2025Capital Expenditures
-93.47MTWDFY2025 · Dec 31, 2025Net Intangibles (CF)
-56.22MTWDFY2025 · Dec 31, 2025Net Acquisitions
1.47MTWDFY2025 · Dec 31, 2025Purchase of Investments
-218.41MTWDFY2025 · Dec 31, 2025Sale of Investments
46.05MTWDFY2025 · Dec 31, 2025Other Investing Activity
-46.78MTWDFY2025 · Dec 31, 2025Net Investing Cash Flow
-311.14MTWDFY2025 · Dec 31, 2025Long-term Debt Issuance
400.00MTWDFY2025 · Dec 31, 2025Long-term Debt Payments
-7.20BTWDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-500.00MTWDFY2025 · Dec 31, 2025Common Dividends Paid
-1.04BTWDFY2025 · Dec 31, 2025Other Financing Charges
-40.27MTWDFY2025 · Dec 31, 2025Net Financing Cash Flow
-8.38BTWDFY2025 · Dec 31, 2025Shares Outstanding
248.65MSharesUpdated Aug 20, 2026Float Shares
193.07MSharesUpdated Aug 20, 2026% Held by Insiders
23.10%vs all stocks
% Held by Institutions
13.99%vs all stocks
Total Cash (MRQ)
2.94BTWD92.27M · vs all stocks (USD)
Total Cash per Share (MRQ)
11.79TWDUpdated Aug 20, 2026Total Debt (MRQ)
2.11BTWD66.13M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2719xCurrent Ratio (MRQ)
2.13xBook Value per Share (MRQ)
27.90TWDUpdated Aug 20, 2026Total Assets
11.35BTWD356.13M · vs all stocks (USD)
Total Current Assets
6.01BTWDFY2025 · Dec 31, 2025Total Liabilities
3.30BTWDFY2025 · Dec 31, 2025Total Non-current Assets
5.34BTWDFY2025 · Dec 31, 2025Total Non-current Liabilities
656.89MTWDFY2025 · Dec 31, 2025Total Current Liabilities
2.64BTWDFY2025 · Dec 31, 2025Cash & Cash Equivalents
2.52BTWDFY2025 · Dec 31, 2025Other Short-term Investments
467.74MTWDFY2025 · Dec 31, 2025Accounts Receivable
1.50BTWDFY2025 · Dec 31, 2025Inventory
1.39BTWDFY2025 · Dec 31, 2025Accounts Payable
261.14MTWDFY2025 · Dec 31, 2025Short-term Debt
1.22BTWDFY2025 · Dec 31, 2025Other Current Liabilities
40.79MTWDFY2025 · Dec 31, 2025Long-term Debt
7.40MTWDFY2025 · Dec 31, 2025Other Non-current Liabilities
269.30MTWDFY2025 · Dec 31, 2025Common Stock (Book)
2.49BTWDFY2025 · Dec 31, 2025Retained Earnings
2.57BTWDFY2025 · Dec 31, 2025Total Shareholders' Equity
8.05BTWD252.67M · vs all stocks (USD)
52-Week Low
71.60TWDUpdated Aug 20, 202652-Week High
87.00TWDUpdated Aug 20, 202652-Week Change
3.95%vs all stocks
Beta
0.1130xvs all stocks
50-Day MA
76.26TWDUpdated Aug 20, 2026200-Day MA
78.75TWDUpdated Aug 20, 2026Avg 10-Day Volume
557.41KSharesUpdated Aug 20, 2026Avg 30-Day Volume
798.28KSharesUpdated Aug 20, 2026Diluted EPS (TTM)
6.96TWDUpdated Aug 20, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Cash Backing With Revenue And Income Streaks
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 5.45: safe zoneNotable
Altman Z-Score: 5.45
High structural barrier to entryNotable
Barrier to Entry: 0.54
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $29.14M, above the global median of $16.24MNotable
Levered free cash flow (USD): 29,142,305.323Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Beijing Scitop Bio-Tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Kexing Biopharm Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Allogene Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Hangzhou AGS Medtech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tectonic Therapeutic Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Hainan Shuangcheng Pharmaceuticals Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tibet Weixinkang Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jinhe Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shanghai Kinetic Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Achieve Life Sciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Hermès International Société en commandite par actions
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash Backing With Revenue And Income StreaksMulti-Year Revenue, Profit, And Income Growth
Lubair Aviation Technology
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash Backing With Revenue And Income StreaksMulti-Year Revenue, Profit, And Income Growth
Bosun Co., Ltd.
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash Backing With Revenue And Income StreaksMulti-Year Revenue, Profit, And Income Growth